Eastern Cooperative Oncology Group performance status

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
H Endocrinology (ATC H) 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Corticosteroid 1 substance
Monoclonal antibody (immune, humanized) 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Karolinska University Hospital Academic
    PREDNISOLONE; TOCILIZUMAB
    2022-501130-33-00 2 countries 2023 n=57
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Karolinska University Hospital Academic 1 Phase II 1
New trials by year
2023
1
← All indication landscapes